image
Healthcare - Medical - Healthcare Information Services - NYSE - US
$ 7.23
-0.823 %
$ 1.26 B
Market Cap
-1.23
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one TDOC stock under the worst case scenario is HIDDEN Compared to the current market price of 7.23 USD, Teladoc Health, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one TDOC stock under the base case scenario is HIDDEN Compared to the current market price of 7.23 USD, Teladoc Health, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one TDOC stock under the best case scenario is HIDDEN Compared to the current market price of 7.23 USD, Teladoc Health, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart TDOC

image
$15.0$15.0$14.0$14.0$13.0$13.0$12.0$12.0$11.0$11.0$10.0$10.0$9.0$9.0$8.0$8.0$7.0$7.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
2.57 B REVENUE
-1.26%
-1.02 B OPERATING INCOME
-310.73%
-1 B NET INCOME
-354.35%
294 M OPERATING CASH FLOW
-16.10%
-124 M INVESTING CASH FLOW
20.66%
8.31 M FINANCING CASH FLOW
-23.42%
640 M REVENUE
-0.00%
-48.2 M OPERATING INCOME
-8.59%
-48.4 M NET INCOME
-45.48%
85.9 M OPERATING CASH FLOW
-22.03%
-29.6 M INVESTING CASH FLOW
4.83%
2.06 M FINANCING CASH FLOW
194.84%
Balance Sheet Teladoc Health, Inc.
image
Current Assets 1.66 B
Cash & Short-Term Investments 1.3 B
Receivables 224 M
Other Current Assets 142 M
Non-Current Assets 1.85 B
Long-Term Investments 0
PP&E 56.6 M
Other Non-Current Assets 1.8 B
36.92 %6.37 %4.03 %51.07 %Total Assets$3.5b
Current Liabilities 942 M
Accounts Payable 33.1 M
Short-Term Debt 0
Other Current Liabilities 908 M
Non-Current Liabilities 1.57 B
Long-Term Debt 1.57 B
Other Non-Current Liabilities 0
36.11 %62.58 %Total Liabilities$2.5b
EFFICIENCY
Earnings Waterfall Teladoc Health, Inc.
image
Revenue 2.57 B
Cost Of Revenue 751 M
Gross Profit 1.82 B
Operating Expenses 2.84 B
Operating Income -1.02 B
Other Expenses -19.6 M
Net Income -1 B
3b3b3b3b2b2b2b2b1b1b500m500m00(500m)(500m)(1b)(1b)(1b)(1b)3b(751m)2b(3b)(1b)20m(1b)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
70.76% GROSS MARGIN
70.76%
-39.73% OPERATING MARGIN
-39.73%
-38.97% NET MARGIN
-38.97%
-67.15% ROE
-67.15%
-28.47% ROA
-28.47%
-39.95% ROIC
-39.95%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Teladoc Health, Inc.
image
300m300m250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -1 B
Depreciation & Amortization 373 M
Capital Expenditures -10.8 M
Stock-Based Compensation 146 M
Change in Working Capital 0
Others 777 M
Free Cash Flow 283 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Teladoc Health, Inc.
image
Wall Street analysts predict an average 1-year price target for TDOC of $12.4 , with forecasts ranging from a low of $9 to a high of $20 .
TDOC Lowest Price Target Wall Street Target
9 USD 24.48%
TDOC Average Price Target Wall Street Target
12.4 USD 71.90%
TDOC Highest Price Target Wall Street Target
20 USD 176.63%
Price
Max Price Target
Min Price Target
Average Price Target
2020181816161414121210108866May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 9
6. Ownership
Insider Ownership Teladoc Health, Inc.
image
Sold
0-3 MONTHS
674 K USD 5
3-6 MONTHS
488 K USD 5
6-9 MONTHS
643 K USD 12
9-12 MONTHS
802 K USD 12
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
141 K USD 2
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks? Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies. fool.com - 3 weeks ago
Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report? Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? zacks.com - 3 weeks ago
Teladoc (TDOC) Flat As Market Sinks: What You Should Know Teladoc (TDOC) reachead $8.64 at the closing of the latest trading day, reflecting no change compared to its last close. zacks.com - 3 weeks ago
Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider In the latest trading session, Teladoc (TDOC) closed at $8.49, marking a +1.19% move from the previous day. zacks.com - 1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC NEW YORK , March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 1 month ago
Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy? Telemedicine specialist Teladoc Health (TDOC 1.53%) has been a terrible investment over the past three years. Once the company's pandemic-fueled business boom cooled down, its revenue and visit growth slowed down considerably while it remained unprofitable. fool.com - 1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC NEW YORK, NY / ACCESS Newswire / March 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 1 month ago
Teladoc Expands Specialty Care Access With Carrum Health Partnership TDOC partners with Carrum Health in a bid to expand access to specialty care. zacks.com - 1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accessnewswire.com - 1 month ago
Carrum Health Selected by Teladoc Health as Centers of Excellence Partner The partnership enables Teladoc Health's employer clients and members more streamlined and fully integrated access to Carrum's value-based Centers of Excellence network for specialty care SAN FRANCISCO , March 13, 2025 /PRNewswire/ -- Carrum Health, the leader in value-based Centers of Excellence (COE) for specialty care, today announced a strategic partnership with Teladoc Health (NYSE: TDOC), the global leader in virtual care. The new arrangement will allow Teladoc Health's providers to seamlessly refer eligible members needing specialty care into Carrum's nationwide network of rigorously vetted, high quality providers. prnewswire.com - 1 month ago
Teladoc Doubles Down on Connected Care With New Partnerships With more than 93 million members, deeper integration of services could lead to higher utilization for TDOC. zacks.com - 1 month ago
8. Profile Summary

Teladoc Health, Inc. TDOC

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 1.26 B
Dividend Yield 0.00%
Description Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Contact 2 Manhattanville Road, Purchase, NY, 10577 https://www.teladochealth.com
IPO Date June 30, 2015
Employees 4620
Officers Michael Minchak Vice President of Investor Relations Mr. Adam Christian Vandervoort J.D. Chief Legal Officer & Secretary Ms. Stella Sanchez Chief of Staff to the Chief Executive Officer & Head of Corporate Marketing Mr. Carlos Nueno President of International Ms. Kelly M. Bliss President of U.S. Group Health Dr. George Byron Brooks BS EE, M.D. Co-Founder Mr. Charles Divita III, CPA Chief Executive Officer & Director Mr. Nikolaos Nanis Chief Technology Officer Ms. Mala Murthy Chief Financial Officer Mr. Joseph Ronald Catapano Cpa Senior Vice President & Chief Accounting Officer